Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Apotransferrin is the iron-free form of transferrin, a glycoprotein responsible for binding and transporting iron in blood plasma. Unlike holotransferrin (iron-bound), apotransferrin does not carry iron but retains the ability to bind ferric ions. It plays a crucial physiological role in maintaining iron homeostasis by accepting and distributing iron among body organs. Apotransferrin is also used as an important transport factor in defined cell culture media and has been studied as a drug delivery vehicle due to its efficient cellular uptake via transferrin receptor-mediated endocytosis[1][2][4][5]. In research settings, it has shown potential therapeutic effects such as increasing hemoglobin levels and improving erythropoiesis in models of thalassemia[2]. Apotransferrin is typically purified from human plasma for laboratory use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on apotransferrin.